Photo pendingAC-262536
Price on application
AC-262536 is a non-steroidal SARM that acts as a partial agonist of the androgen receptor. It offers moderate anabolic activity with significantly reduced androgenic effects, making it a subject of interest for milder research applications.
Research Profile
AC-262536 was developed by Acadia Pharmaceuticals as a selective androgen receptor modulator with a partial agonist profile. In animal studies, it demonstrated approximately 66% of the anabolic potency of testosterone while exhibiting only 27% of its androgenic activity. This favorable ratio suggests a wider therapeutic window for applications where muscle and bone support are desired without significant hormonal disruption. AC-262536 has also been investigated for potential neuroprotective properties, as androgen receptors play roles in central nervous system function.
Technical Details
- Chemical Formula
- C18H18N2O
- Synonyms
- AC-262536, Accadrine
- Molecular Weight
- 278.35 g/mol
- CAS Number
- 870888-46-3
- Active Ingredient
- 350mg (10mg per capsule)
- Shelf Life
- 36 months